By ancient Braves Journal tradition, whenever we add a new player, particularly a reasonably prominent one, there’s a writeup to introduce him to the crowd. Ryan already wrote up the acquisition but I thought it was worth going into a bit more depth on the player.
We all know who he is, of course. The Rangers signed Jurickson Profar out of Curacao sixteen years ago, not too long after his sixteenth birthday; he’ll celebrate his 32nd in two weeks. He was highly precocious and got a cup of coffee in the majors when he was 19, by which time he was a top-ten prospect in baseball. He was the consensus overall top prospect in baseball going into the 2013 season – BA, BP, and MLB Pipeline all agreed on that – and his potential seemed limitless.
A brief comparison to Byron Buxton may be worthwhile; they were frequently compared at the time, as titanic talents whose promise was nearly undone by injury. Buxton was taken second overall in the 2012 draft and was the #1 prospect in baseball by 2014, a year Profar entirely missed due to injury. Buxton has now spent 10 seasons in the majors and has a total of 772 games played; he’s only cleared 100 games twice, including last year. He has essentially settled in as the Tyler Glasnow of position players, having produced more than 20 WAR in his career despite all his time missed.
Profar has spent 11 seasons in the majors now, and played 1119 games, but he’s only been worth around nine wins, nearly half of them last year. While Buxton’s injuries have not crushed his defensive performance, Profar has gone from a well-regarded shortstop prospect to a poor defensive corner outfielder.
But he remains a fine hitter. While last year’s performance was excellent, it was not the only instance of sustained fine play in his career. In general, while his defense is only acceptable by comparison with Marcell Ozuna or Jorge Soler, he’s been a hitter with pretty good power and very good plate discipline and contact rates.
In 2018, 2020, 2022, and 2024 he posted OPS+ over 100, and while last year he set a career high in homers with 24, he also hit 20 homers in back-to-back years in 2018 and 2019. For his career, he has a walk rate of 10%, a strikeout rate of 16%, and a contact rate of 83%. His Chase, Whiff, K%, and BB% numbers have all been deep-red on Baseball-Savant his entire career, even while last year’s exit velocity numbers seemed to come out of nowhere.
As I’ve noted in the comments, Alex Anthopoulos seems to have a history of betting on players who make extraordinarily hard contact (e.g. Jorge Soler, Marcell Ozuna, Josh Donaldson) as well as players who have exhibited a major recent improvement in their play (e.g., his extensions of Ozuna, plus Spencer Strider, Jose Bautista, and Edwin Encarnacion).
The contract values Profar as roughly a two-win player, which seems quite reasonable. But if Profar’s able to hang onto his improvement in his power numbers, he could be a bit better than that, defense notwithstanding. The Braves obviously benefit from their longstanding connection with Curacao; Profar clearly was excited to come here, and I hope that he and Ozzie Albies can help each other as they both work on remaking themselves as offensively focused players whose defense has been greatly weakened by injury.
This deal feels to me as having relatively moderate risk given the clear upside in Profar’s bat, and it addresses one of the team’s core weaknesses. At this point, Jarred Kelenic is the team’s fourth outfielder, and when Ronald Acuña returns, Kelenic will probably become Profar’s defensive caddy. Perhaps Profar can help Kelenic, too, as another former top prospect who struggled for years to live up to his potential.
The team isn’t perfect and I hope that Anthopoulos isn’t finished. But this was a great deal.

who hangs up first?
https://fansided.com/this-braves-padres-trade-would-give-atlanta-the-ultimate-jack-flaherty-pivot
I’m not trading Waldrep and pieces for one year of control of a guy with one whole strong year as a starter.
With Laureano and Flaherty off the market, I’m not sure there’s anything more we can do. Maybe a Cease or King trade. I think we should expect to roll with what we’ve got.
Looking at the roster there does seems to be space for one more big move whether by FA or trade. Gotta keep hoping but #2 projection at two different sources is not bad even if somewhat unreasonable.
Hearing the prospect guys pumping up ASS as someone who’s going to take a huge leap this year is continuing to make me want to keep a spot open for him. I would be ok with getting somebody like Andrew Heaney for depth if we did something. But I don’t want to give up a blue chip prospect for one year of King or even Cease, and I’m sure AA doesn’t either.
Rob, where have you read that about ASS?
The Locked On Braves’ podcast guy Jake whatever seemed to be really encouraged with ASS. Felt like he was going to contend for a spot in the rotation. Problem with ASS and Waldrep is that they didn’t show much in 2024, but I don’t think it’s wise to say that there hasn’t continued to be development.
He also said that Waldrep would be the guy he would trade, but man, I really don’t want to do that on a one-year rental. There has to be someone else out there worth grabbing for Waldrep.
I hate to sell low on anyone. AJSS and Waldrep were top 100 prospects a year ago. Best to keep them, unless of course you think they can only go lower, which is doubtful.
I agree, I hate selling low unless our scouts basically think that they’ll never regain their former prospect status.
I’m in favor of trading Waldrep now while he can still be considered a starting pitching prospect. I fear after this season he’ll no longer be viewed that way. That said, I think he has big upside in the bullpen if we keep him; throwing harder and hitters seeing less of the splitter will help him a lot.
Following up on Nathan’s and Stampton’s points in the last thread about no team being willing to trade anything of value for Soto’s contract because they all passed on the opportunity to get him for that contract just a few months ago, I agree in general, but I think you have to be somewhat subjective in assigning trade value, because teams don’t all have the same valuation of the WAR each player would bring. First of all, teams may have different projections of a player’s future WAR – they may be more or less concerned about an injury history, or about how he will hit in their park, or about his consistency of production, or they may think they can fix his swing – that sort of thing.
Second and I think more importantly, there’s a difference in the value of that player’s WAR to each team. If you’re in big-market NY, the extra benefit in revenue from each additional win is a lot greater than if you’re in Tampa Bay, and the extra value of a win if you’re the Cubs and not too far from making the postseason is a lot greater than if you’re the White Sox. Also, if you’re trying to value a player’s WAR, what you currently have at the position matters, because if you get the player, then you have to either move the incumbent to a new position (where he presumably is less valuable) or trade him, and there are transaction costs like possibly not getting full value for that player because there are only so many teams that would be interested and have pieces you could use. That said, a few months ago the Mets were the team that projected Soto’s WAR and valued that WAR in the combination that was most favorable to Soto, so it’s not likely that the numbers would’ve changed dramatically by now without much new information.
At the same time, while in the abstract Soto has less trade value than someone on a rookie deal, that probably applies to the White Sox and many other teams but not to the Mets. If the Mets traded Soto for a player on a rookie deal with more abstract trade value, they would have to find a way to replace most of Soto’s WAR, and there are very few individual players available who can come close to doing that, so they’d have to start using the money saved to try and upgrade at several positions, which gets more difficult the better your team is (because it costs more to go from a 3-WAR player to a 5-WAR player than it does to go from a 1-WAR player to a 3-WAR player). You can’t just shuffle players around infinitely, because options are limited and transaction costs are a thing.
Anyway, since Soto has different values to different teams, his trade value is going to be different for different teams too. It seems too complicated to try and calculate each player’s trade value to each team and then average them, so I think a certain amount of subjectivity is necessary.
Sure, there’s a certain bit of variance and a large degree of complexity. I’d hesitate to call it ‘subjectivity,’ though; that implies to me a comparison to personal taste. It’s subjective what flavor of ice cream tastes the best, because all that matters there is preference, which is purely internal to each person. Soto’s trade value is just complicated, not subjective.
If we’re committed to ranking trade value of individual players, I agree with you that we have to do some degree of abstraction away from the exact circumstances. But no plausible version of that process gives rise to the result that Soto is top 20 players in trade value, or even top 50. I think it’s pretty clear, and stampton said as much, that the ranker just put Soto top 20 because he’s a really good player, and that’s to straightforwardly misunderstand what people mean by ‘trade value.’
I agree it is complex and there may be a phenomenon of increasing returns in war. N short, a 2 war player might generally cost you $15 million per year, but often a 6 war player is only $30 million. That is what I have seen anecdotally. And you’re right that there is a problem of scarcity where maybe trading Soto for Schwellenbach is the correct move but the Mets wouldn’t do it because they can’t go sign an outfielder to replace Soto, or at least not at this point in the offseason.
But yeah, I concur with Nathan. Soto’s actual trade value is low in terms of what the Mets could get for him if they inexplicably tried to trade him now. On the other hand, Schwelly would net a huge package if we moved him. It is likely that AA said no to Crochet for him.
I hadn’t realized that Alonso had a pretty terrible walk year last year: 2.6 WAR. Only getting 2 years is pretty crazy, but Alonso is really just not that good.
Keith Law published his prospects list:
https://www.nytimes.com/athletic/6094913/2025/02/06/atlanta-2025-top-20-prospects-keith-law/
Beyond guys like Ritchie, he likes some of our Latin American teenagers, particularly John Gil (?). In general though, there does seem to be a bit of depth in the system, it’s just far away.
Waldrep apparently is viewed by consensus as a reliever, for what it’s worth.
Alonso is exactly the type of player I do not like to bet on to age well. He’s of the Santander and Uggla mold. I think his deal was about right, and there’s a good chance it’s his last multiyear deal.
Speaking of which, why wouldn’t we sign Iglesias???
https://www.sportingnews.com/us/mlb/new-york-mets/news/mets-make-harsh-jose-iglesias-decision-alongside-54-million-pete-alonso-shocker/3174f699f1a346daedfc2ac6
I asked Keith about Waldrep last July, and he was pretty dismissive of my reliever concerns:
https://meadowparty.com/blog/?s=Klawchat+
Kip: At what point would you transition Waldrep into a relief role? He didn’t get a lot of swing and misses in a small MLB sample, even with that split.
Keith Law: Uh, he’s less than a year out of the draft.
I’m curious what changed. My guess is more scouts have seen Waldrep and a consensus has formed. His fastball movement was just as much of an issue then as it is now.
A lot of people thought we should have taken Colin Houck but it doesn’t look like he’s going to work out. He didn’t make Keith’s top 20 Mets prospect list and Keith said, “there’s nothing redeeming in his pro performance to date by any perspective.” Yikes.
For years it was a fait accompli that the Braves would take a high school prospect from Georgia and I’m so happy we’ve moved away from that.
And he doesn’t have another pitch. His splitter doesn’t work as a weapon unless he can keep hitters honest by having other pitches he can throw for strikes without getting massacred.
If he had another pitch, I think it’d be a different story. Tale as old as time!
Well the super bowl is mercifully over. Maybe next season the Braves will be in it.
Testing
Is there a glitch in the matrix, Ryan?
https://x.com/JonPgh/status/1889012681983553538
There are all these random metrics that clearly show that Michael Harris II is a freak talent. And Fangraphs projects him having a huge year. I think this might be the year where he becomes a franchise player.
He is a freak talent. There is one thing keeping him from being a franchise player. He swings at almost everything.
https://x.com/DOBrienATL/status/1889417091024908454
Diekman is obviously interesting. He was really good for Tampa Bay in 2023: 2.18 ERA, 3.21 FIP, 45.1 IP. However, he was terrible for the Mets last year.
Covey was decent for Philly in 2023: 3.69 ERA, 4.26 FIP, 39 IP.
Kuhl has never been good but had a decent FIP (4.10) for the White Sox last year.
Seems like some very good candidates for cheap bullpen help. Kuhl is a good mop-up guy who might be able to spot-start. He has been a replacement level starting pitcher over his career. We could’ve used one of those at various points last season.
How old is Diekman now? 70? You know what they say about left-handed pitchers…
I’m OK with having question marks in the bullpen if we add an established starter, and I’m OK with having question marks in the rotation if we add an established bullpen piece. But having question marks in both places is baffling for a team trying to win the World Series.
Based on the offseason, we’re not trying to win the World Series.
If you look at the fact that AA has never made a splashy pitcher acquisition, you would think he never tries to win the world series. In fact, that is not his philosophy. He is trying to produce a permanent playoff contender. It is smart fiscally, but it is also smart when you consider the diminishing returns for payroll to WS odds. I have been a vocal critic of his because I think he takes this smart approach too far.
That aside, there is a lot of uncertainty about what we have (too many players needing to rebound/heal), so it is totally unsurprising that he is not going all-in. If several of our players rebound, you can be sure he will make a trade if needed in-season and possibly make a bigger acquisition next season.
https://x.com/luzthegoosey/status/1889838167269974176?s=46&t=WSNPrB2JyUoeKSn2PZsXZg
Derp.
New post: